A Chinese man has transferred more than 29 percent of HNA Group of China to a private foundation, adding to the questions about the firm’s structure and political connections.
NYS Entity Status
NYS Filing Date
JUNE 14, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - HANDEN INVESTMENT GROUP USA, LTD.
2013 - HANDEN GROUP USA, LTD.
Around the Web
- Behind an $18 Billion Donation to a New York Charity, a Shadowy Chinese Conglomerate
By MICHAEL FORSYTHE and ALEXANDRA STEVENSON - Wednesday Jul 26, 2017
- Chinese auto group invests millions in next-gen cars
By Clayton "CJ" Jacobs - Tuesday Jun 6, 2017
China’s Guangzhou Automobile Group Co. Ltd, known as GAC Group, announced at their recent board of directors meeting that they plan to spend $88 million on a new subsidiary focused on electric vehicles.The new subsidiary will be known as Guangzhou Automobile New Energy Automobile Co., Ltd. The first registered capital will be half of the total investment amount with the remaining $44.1m being available based on project requirements.GAC Group — founded in 1997 and was acquired by Guangzhou Automobile Industry Group in 2005 — said they plan on achieving a new energy vehicle...Read More
- Coat maker claims Vince Camuto ruined its business
By Lisa Fickenscher - Wednesday Sep 27, 2017
A New York-based coat maker claims Vince Camuto has left it in the cold as the fashion label cozies up with its new owner. Outerwear manufacturer Fleet Street Ltd. has filed a complaint against Vince Camuto Group with the American Arbitration Association, alleging that the fashion label has moved to give its women’s coat business...
- Detained Samsung scion’s wealth just topped $2 billion
By Reuters - Friday Oct 13, 2017
SEOUL – Jay Y. Lee, the billionaire heir to South Korea’s Samsung Group, should find some comfort that its crown jewel Samsung Electronics Co Ltd has reported record profit every quarter since he was jailed in February, making him even richer. Detained over charges that he bribed former president Park Geun-hye, Lee has since missed...
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]